This website uses cookies to give you the best user experience. If you continue without changing your settings we'll assume you are happy to receive all RSC cookies. You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions are also obtainable from the privacy link at the bottom of any RSC page.
Lite Version|Standard version
Home > MedChemComm >
To gain access to this content please
Log in via your home Institution.
Log in with your member or subscriber username and password.
Download


Buy PDF Add PDF to Basket (£42.50*)
*Exclusive of taxes
This article contains 5 page(s)
Abstract | Cited by

A computational strategy was used to design helical peptides that can bind to tumor necrosis factor-α (TNFα) dimers to prevent active trimer formation. Three designed peptides showed TNFα inhibition at the cellular level. Chemical crosslinking and mass spectrometry studies verified that these peptides function by breaking TNFα trimers.

Graphical abstract: De novo design of helical peptides to inhibit tumor necrosis factor-α by disrupting its trimer formation

Page: ^ Top


Enter Keywords, author, title,reference, or DOI
Log in | Register